scispace - formally typeset
C

Clive Smith

Researcher at Imperial College London

Publications -  17
Citations -  992

Clive Smith is an academic researcher from Imperial College London. The author has contributed to research in topics: Cytokine & Tumor necrosis factor alpha. The author has an hindex of 12, co-authored 17 publications receiving 961 citations. Previous affiliations of Clive Smith include Charing Cross Hospital.

Papers
More filters
Journal ArticleDOI

Functional consequences of a polymorphism affecting NF-kappaB p50-p50 binding to the TNF promoter region.

TL;DR: Using an adenoviral reporter assay, the variant which binds p50-p50 results in a reduction of lipopolysaccharide-inducible gene expression in primary human monocytes and illustrates the potential for genetic modulation of inflammatory gene regulation in humans by subtle nucleotide changes that alter the relative binding affinities of different forms of the NF-κB complex.
Journal ArticleDOI

Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP

TL;DR: It is found that MyD88 and Mal/TIRAP are essential for LPS-induced I kappa B alpha phosphorylation, NF-kappa B activation, and interleukin 6 (IL-6) or IL-8 production in fibroblasts and endothelial cells in a pathway that also requires IKK2.
Journal ArticleDOI

Evidence for a dual mechanism for IL-10 suppression of TNF-alpha production that does not involve inhibition of p38 mitogen-activated protein kinase or NF-kappa B in primary human macrophages.

TL;DR: To the authors' knowledge, this is the first time that a dual mechanism for IL-10 function has been demonstrated and may explain the diversity previously ascribed to the complex mechanisms ofIL-10 anti-inflammatory activity.
Journal ArticleDOI

Is NF-kappaB a useful therapeutic target in rheumatoid arthritis?

TL;DR: The effects of NF-κB blockade in rheumatoid arthritis, inflammation and immunity, and consider possible therapeutic targets within the NF-σκB family are discussed.
Journal ArticleDOI

NF-kappaB-inducing kinase is dispensable for activation of NF-kappaB in inflammatory settings but essential for lymphotoxin beta receptor activation of NF-kappaB in primary human fibroblasts.

TL;DR: Investigation of the role of NIK in LPS, IL-1, TNF-α, and lymphotoxin (LT) βR signaling in primary human cells and T NF-α expression from rheumatoid tissue shows that, in the primary systems tested, NIK has a restricted role in LTβR signaling and is not required by the other stimuli tested.